Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-05, Stock:PFE, The news for the past five days is as follows:
2020-12-28: NEWS1: AstraZeneca Jumps On Reports Its Vaccine Could Gain U.K. Nod On Tuesday.NEWS2: LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA.NEWS3: Myovant Sciences Hits Record High On Development Deal With Pfizer.NEWS4: Doctor: We need to work on communicating 'what the vaccine is and how it works'.NEWS5: Dr. Fauci warns COVID-19 outbreak could worsen post-holidays.NEWS6: Novavax Starts a Late-Stage Coronavirus Vaccine Clinical Trial.NEWS7: Emirates Delivers First COVID-19 Vaccines To UAE.NEWS8: WRAPUP 2-EU's marathon COVID vaccination drive off to uneven start.NEWS9: Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion.NEWS10: Getting COVID-19 vaccines to rural America will be difficult — here’s what it will take to overcome that.NEWS11: Why Myovant Sciences Stock Is Soaring Today.NEWS12: CORRECTED-WRAPUP 1-EU's marathon COVID vaccination drive off to uneven start.NEWS13: Moderna, Pfizer vaccine trials were the ‘highest of quality’: vaccine expert.NEWS14: ROCE Insights For Pfizer.NEWS15: Top 5 Dow Stocks That Helped the Index Gain in 2020.NEWS16: Oil Resumes Slide on Worries Over Demand Amid New Covid Variant.NEWS17: 3 Restaurant Stocks to Gain Big With the Vaccine Rollout.NEWS18: McKesson Stock May Be the Real Covid Vaccine Winner. Here’s Why..NEWS19: Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug.NEWS20: UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion.NEWS21: Why isn't more COVID-19 vaccine available immediately?.NEWS22: 5 Stocks That Could Directly Gain From Pfizer's Vaccine Success.NEWS23: Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion.NEWS24: Is Pfizer Stock A Buy On A New U.S. Supply Deal For Covid Vaccine?.NEWS25: A Vaccination Expert On What Investors Need To Know About COVID Vaccines Now.NEWS26: Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health.NEWS27: EU says Pfizer to complete supply of first 200 mln COVID shots to Europe by Sept.NEWS28: Piecemeal data releases threaten to undermine Sinovac's COVID-19 vaccine.NEWS29: CORRECTED-Approval of Oxford/AstraZeneca COVID shot could help relax COVID restrictions, minister says.NEWS30: Pfizer delayed delivery of new batch of vaccine to Spain by one day, minister says.
2020-12-29: NEWS1: Gold Up, Amid Senate Delay on U.S. Stimulus Checks Increase Vote.NEWS2: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS3: Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock.NEWS4: European Union Set To Purchase 100M More Doses Of Pfizer COVID-19 Vaccine.NEWS5: Why Arcturus Therapeutics Stock Crumbled On Its Covid Vaccine Update.NEWS6: Top-Performing Biotech ETFs Amid the COVID-19 Crisis.NEWS7: Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations.NEWS8: Health experts slam delayed COVID vaccine rollout in U.S. as early effort falls far short of expectations.NEWS9: Germany says it needs third COVID vaccine to make inoculation universal.NEWS10: 'It’s really important to have lofty goals when we think about vaccinations': Doctor.NEWS11: Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021.NEWS12: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®.NEWS13: Why Arcturus Therapeutics Stock Is Plunging Today.NEWS14: Arcturus Therapeutics shares slide 55% after COVID vaccine data are deemed ‘underwhelming’.NEWS15: Myovant (MYOV) Up on Collaboration With Pfizer for Relugolix.NEWS16: Mexico expects 100,000 Pfizer vaccines by early January.NEWS17: Pfizer (PFE) Lorbrena First-Line sNDA Gets FDA Priority Review.NEWS18: Ireland begins COVID-19 vaccinations with 79-year-old woman.NEWS19: Company News for Dec 29, 2020.NEWS20: EU is asked to approve extra dose from Pfizer vaccine vials.NEWS21: U.S. COVID-19 cases surpass 18 million, death toll tops 335,000.NEWS22: Three More Coronavirus Vaccines Expected by Early 2021.NEWS23: UK received 22 deliveries of Pfizer/BioNTech vaccine by Dec. 25, says PM's spokesman.NEWS24: Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes.NEWS25: Wall Street Opens at New Highs on Hopes for Stimulus Boost; Dow up 130 Pts.NEWS26: Dubai aims to inoculate 70% of population with Pfizer vaccine in 2021.NEWS27: Indonesia secures vaccine deals with Pfizer, AstraZeneca.NEWS28: China Is Struggling to Get the World to Trust Its Vaccines.NEWS29: Study says Britain must vaccinate two million a week to prevent a third COVID-19 wave.
2020-12-30: NEWS1: Oil Down, With Immediate COVID-19 Fears Overshadowing Vaccines Progress.NEWS2: Markets Close Higher on Penultimate Trading Day of 2020.NEWS3: EXPLAINER-How does AstraZeneca's vaccine compare with Pfizer-BioNTech?.NEWS4: Asian Stocks Up Over Vaccine and Global Economic Recovery Hopes for 2021.NEWS5: AstraZeneca Wins U.K. Authorization For Covid Vaccine; Shares Edge Higher.NEWS6: Column: Unsurprisingly, Trump's rollout of the COVID vaccine is an utter fiasco.NEWS7: Shots first, questions later: Britain's new COVID-19 vaccine rollout approach.NEWS8: Pfizer and Brazil regulator in talks to speed up emergency vaccine approval.NEWS9: Merck Had a Disappointing 2020. Why Its Strategy Could Pay Off in 2021..NEWS10: Astra’s Covid-19 Vaccine Won Approval, But How Good Is It?.NEWS11: New COVID-19 variant first found in UK arrives in U.S..NEWS12: Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More.NEWS13: EXPLAINER-How does AstraZeneca's vaccine compare with Pfizer-BioNTech?.NEWS14: Coca-Cola (KO) Could Post Strong 2021 Returns.NEWS15: Wall Street Stories That Hit Headlines in 2020.NEWS16: The 3 Safest Stocks to Buy With Your Stimulus Money.NEWS17: Clovis (CLVS) Seeks Permission for Clinical Study on Novel Drug.NEWS18: Why Is Everybody Talking About Novavax Stock?.NEWS19: UPDATE: Coronavirus tally: Global cases of COVID-19 top 82 million as U.K. authorizes third vaccine.NEWS20: Beyond Pfizer and Moderna: What Investors Need to Know About the Next COVID Vaccines in The Pipeline.NEWS21: Swiss canton says person died after COVID-19 shot, unclear if there is a link.NEWS22: UK Health Authorities Approve AstraZeneca/Oxford University Coronavirus Vaccine.NEWS23: California nurse tests positive over a week after receiving Pfizer COVID-19 vaccine- ABC.NEWS24: Czechs approve squeezing extra dose from Pfizer vaccine vials.NEWS25: Myovant Shares Soar on $4.2 Billion Development Collaboration with Pfizer; Target Price $42.NEWS26: Could Benjamin Netanyahu’s Likud Party Be His Achilles’ Heel?.NEWS27: Moderna Makes COVID-19 Vaccine Available To Board, Staff, And Contractors On Priority.NEWS28: Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union.
2020-12-31: NEWS1: Why Pfizer is the Cheapest Coronavirus Vaccine Play.NEWS2: Moderna Stock Is More Than The Covid-19 Vaccine.NEWS3: Vaccine rollout ’is the largest, logistical challenge’ that the U.S. has faced in modern history: doctor.NEWS4: British family doctors criticise change of plan on vaccine boosters.NEWS5: A Few Reasons for Investor Optimism in the New Year.NEWS6: Pfizer: No Data to Show Single Vaccine Dose Protects Beyond 21 Days.NEWS7: Pfizer: Single Dose of Vaccine Doesn't Protect Beyond 21 Days.NEWS8: AstraZeneca (AZN) COVID-19 Vaccine Gets Authorization in UK.NEWS9: How to Stay Ahead of a Mutating Virus.NEWS10: Novavax Is Inching Closer, But Its Vaccine Better Be Special.
2021-01-04: NEWS1: AstraZeneca Pops On U.K. Plans As Covid Vaccine Nabs India Approval.NEWS2: Column: Pfizer, Moderna expect billions in profits from COVID vaccines. That's a scandal.NEWS3: Doctor on COVID-19 spike: 'We're preparing for a surge of more patients over the next four weeks'.NEWS4: Coronavirus update: Moderna raises vaccine production target; new virus strains cause concern.NEWS5: Why Ocugen Stock Is Crushing It Today.NEWS6: Why BioNTech Stock Is Jumping Today.NEWS7: Outlook for biotech companies in 2021.NEWS8: 3 Takeaways for Investors in mRNA Vaccine Stocks.NEWS9: Markets Pick Up in 2021 Right Where They Left Off.NEWS10: My Favorite Biotech Stock for 2021.NEWS11: 1 Green Flag and 1 Red Flag For Pfizer's and Moderna's Vaccine Rollouts.NEWS12: Vaccine Rollout: France Is Failing at What It’s Meant to Do Best.NEWS13: US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency.NEWS14: German health ministry examines delaying second COVID-19 vaccine shot - document.NEWS15: Roll out of second vaccine a 'triumph of British science'- UK's Hancock.NEWS16: European Stock Futures Higher; Vaccine Rollout Eyed.

Answer: Rise